Yungpo Bernard Su - Nebraska Cancer ...

Dr. Yungpo B Su, MD

Claim this profile

Nebraska Methodist Hospital

Studies Squamous Cell Carcinoma
Studies Throat Cancer
8 reported clinical trials
12 drugs studied

Area of expertise

1Squamous Cell Carcinoma
Yungpo B Su, MD has run 3 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
Stage III
Stage IV
PD-L1 positive
2Throat Cancer
Yungpo B Su, MD has run 2 trials for Throat Cancer. Some of their research focus areas include:
Stage III
Stage IV
HPV negative

Affiliated Hospitals

Image of trial facility.
Nebraska Methodist Hospital
Image of trial facility.
Heartland Oncology And Hematology LLP

Clinical Trials Yungpo B Su, MD is currently running

Image of trial facility.

Pembrolizumab + Radiation vs Chemotherapy + Radiation

for Head and Neck Cancer

This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
Image of trial facility.

Radiation Therapy + Cisplatin

for Head and Neck Cancer

This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria

More about Yungpo B Su, MD

Clinical Trial Related5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Yungpo B Su, MD has experience with
  • Nivolumab
  • Cisplatin
  • Pembrolizumab
  • Ipilimumab
  • Seribantumab
  • Intensity-Modulated Radiation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Yungpo B Su, MD specialize in?
Is Yungpo B Su, MD currently recruiting for clinical trials?
Are there any treatments that Yungpo B Su, MD has studied deeply?
What is the best way to schedule an appointment with Yungpo B Su, MD?
What is the office address of Yungpo B Su, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security